Controversy Surrounds Penny Mordaunt's Appointment at British American Tobacco

Apr.11.2025
Controversy Surrounds Penny Mordaunt's Appointment at British American Tobacco
Former UK Conservative Party leadership candidate and defense minister Penny Mordaunt joins BAT advisory role, raising ethical concerns.

Key Points:

Former UK Conservative Party leadership candidate and Defense Minister Penny Mordaunt has accepted a consultancy position with British American Tobacco (BAT), advising on harm reduction strategies.

The Business Appointments Consultative Committee pointed out that former cabinet ministers like Mordaunt may provide unfair government access opportunities for British American Tobacco and advised him to avoid direct contact with the government.

Anti-smoking organizations are skeptical of the "harm reduction" promises made by British American Tobacco, as they rely on cigarette sales. They question whether the appointment of Mordaunt is in the public interest.


According to The Guardian's report on April 10th, Penny Mordaunt, a former British Conservative Party leadership candidate who has held several cabinet positions including Defense Secretary and Leader of the House of Commons, has taken on a new role as an advisor for British American Tobacco (BAT), responsible for providing guidance on "harm reduction.

 

In 2024, after losing her seat in parliament, she will be working as a paid consultant for the Transformation Advisory Group at British American Tobacco (BAT).

 

The senator abstained from voting on the gradual smoking ban proposed by Rishi Sunak last year, and was in charge of managing the government's legislative agenda before the bill failed to pass parliament before the election.

 

The Labour Party had urged the government to break with tradition and push forward with the Tobacco and E-cigarette Bill, even though it was in the initial stages at the time. With the Labour Party pushing for it, the bill has once again been put on the agenda.

 

Penny Mordaunt's new job was disclosed by the Advisory Committee on Business Appointments, which stipulates that she cannot lobby for the government or engage in any public contracts consulting within two years of leaving office.

 

The committee pointed out that "British American Tobacco has a keen interest in government policies and regulations, and focuses resources on influencing government decisions - such as lobbying for lower tobacco taxes, enacting e-cigarette legislation, and preventing counterfeit goods.

 

The committee stated that due to changes in government and the passage of time, the risk of Mordaunt gaining access to potentially helpful information regarding British American Tobacco is limited.

 

However, the committee added, "Although you claim not to engage in lobbying, your previous role as a cabinet minister may be perceived as providing unfair access to and influence over the government for British American Tobacco. Therefore, the committee recommends that you should not represent the company directly in dealings with the government, as this would pose a significant risk under government regulations.

 

Anti-smoking activists are skeptical of tobacco companies' claims of "reducing harm," believing that these companies rely on cigarette sales.

 

In recent years, it has been unusual for former ministers to work for tobacco companies, and several members of parliament have been criticized for accepting hospitality from the tobacco industry. Ken Clarke, a former Conservative Chancellor and Health Secretary, worked at British American Tobacco from 1998 to 2007.

 

Regarding the appointment of Mordaunt, Kingsley Wheaton, the Chief Corporate Officer of British American Tobacco, stated,

 

British American Tobacco has launched a manifesto of change... It is based on the best practices of Tobacco Harm Reduction (THR) and science. To accelerate this goal, we are aware that challenging our conventional thinking with alternative perspectives will greatly contribute to success. The THR Advisory Committee is designed for this purpose.

 

At present, Mordaunt has not yet made any comments on the matter.

 

Main image source: Ian Forsyth/Getty Images

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Defines Enforcement Focus for Unauthorized E-Cigarettes and Nicotine Pouches
FDA Defines Enforcement Focus for Unauthorized E-Cigarettes and Nicotine Pouches
The U.S. Food and Drug Administration issued guidance on May 8, 2026, titled “Enforcement Priorities for Certain New Tobacco Products Marketed Without Premarket Authorization.” The document describes FDA enforcement policies for certain electronic nicotine delivery system products and nicotine pouch products marketed without premarket authorization.
May.09 by 2FIRSTS.ai
FDA Proposes Foreign Tobacco Factory Registration Rule to Tighten Import Oversight
FDA Proposes Foreign Tobacco Factory Registration Rule to Tighten Import Oversight
The FDA has proposed a rule requiring foreign tobacco manufacturers to register facilities and list products before exporting to the U.S. If finalized, the rule could affect overseas OEM/ODM factories, contract manufacturers, specification developers, bulk product makers, and repackaging or relabeling firms. FDA says the proposal would help identify unauthorized imported tobacco products, including e-cigarettes.
Special Report
Jun.26
Capital Group Takes 5.61% Stake in KT&G, Joining Major Foreign Shareholders
Capital Group Takes 5.61% Stake in KT&G, Joining Major Foreign Shareholders
KT&G disclosed in a regulatory filing on Friday that Capital Research and Management Company, the investment management arm of Capital Group, had acquired a 5.61% stake through purchases made on April 22 and May 4. The move places Capital Group among KT&G’s prominent foreign shareholders, alongside BlackRock, First Eagle Investment Management and Singapore’s sovereign wealth fund GIC.
May.08 by 2FIRSTS.ai
South Korea Moves Against Synthetic Nicotine Regulatory Gap as Three Companies Face Tobacco Business Act Probe
South Korea Moves Against Synthetic Nicotine Regulatory Gap as Three Companies Face Tobacco Business Act Probe
South Korea’s Ministry of Finance and Economy said on May 4 that it requested the Daejeon Metropolitan Police Agency and Gyeonggi Nambu Provincial Police Agency to investigate three sales companies on suspicion of violating the Tobacco Business Act.
May.06 by 2FIRSTS.ai
South Korea Rejects 16 Trillion Won Tax-Evasion Claim Over Chinese Synthetic Nicotine
South Korea Rejects 16 Trillion Won Tax-Evasion Claim Over Chinese Synthetic Nicotine
The South Korean government rejected allegations that Chinese synthetic-nicotine e-liquids were linked to about 16 trillion won in tobacco tax evasion, saying China does not ban synthetic nicotine exports and the estimate is difficult to verify, while acknowledging that pre-law synthetic-nicotine inventory is effectively difficult to tax.
Market
Jun.25
Product | KT&G Expands lil AIBLE 3.0 Sales to Seoul Convenience Stores, Launches Two New AIIM Variants
Product | KT&G Expands lil AIBLE 3.0 Sales to Seoul Convenience Stores, Launches Two New AIIM Variants
According to South Korean media reports, KT&G has expanded sales of its heated tobacco device lil AIBLE 3.0 to convenience stores across Seoul starting May 13. The convenience-store version is offered in the exclusive OUD GRAY color. On the same day, KT&G also launched two new dedicated consumables for the lil AIBLE platform—AIIM REMIX and AIIM ICESPOT—at convenience stores nationwide, each priced at KRW 4,800.
Market
Jun.01